Experience Fenwick Represents Status Money in Convertible Note Financing Agreement with SixThirty Ventures February 5, 2020
Experience Fenwick Represents Arcutis Biotherapeutics in $183.3M Initial Public Offering February 4, 2020
Blog Biotech & Life Sciences Trends to Consider Following JPM 2020: M&A, Venture Capital and More January 23, 2020